This project aims at providing a roadmap and implementation guidance for the adoption and the development of localised solutions based on the HL7 v2, CDA and FHIR standards. In terms of recent HL7 International jargon, these standards are referred to as HL7 product families.
The purpose of the roadmap is to outline the current implementation approaches for the three technical approaches of HL7 v2, HL7 CDA, and HL7 FHIR along with a projection of their use into the future. This roadmap is the product of an inclusive conversation amongst stakeholders within these platform domains (or product families in the HL7 speak) to capture the discussion that regularly transpires when one is explaining the current and future states of these technologies to other colleagues within e-health.
Such a roadmap would be of value for assist decision makers in digital health projects and organisations facing the problem of how to support the future investments in solutions based on these standards, while taking into account the their existing and past investments. These decisions may be within the scope of a specific product family, such as HL7 V2 product family, and various versions of it, or across product families, where new technologies have emerged, such as in the context of the impact of FHIR product family on the CDA and V2 products and solutions.
A guidance is a type of informative document that describes principles, best practices, and general advice but is not directly related to implementation of one or more specifications. It is nonetheless more technical in nature than a roadmap, and would be aimed to intended for those stakeholders faced with the problem of developing localised solutions based on the existing Australian standards, or simply the adoption of these standards, including support for conformity assurance processes, while taking into account capabilities available by different vendor offerings.